Cargando…
Deferoxamine has the Potential to Improve the COVID-19-Related Inflammatory Response in Diabetic Patients
The clinical state of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been considered a pandemic disease (COVID-19) that is rapidly spreading worldwide. Despite all global efforts, the only treatment for COVID-19 is supportive care and there has been no efficient treatment to fight...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227407/ https://www.ncbi.nlm.nih.gov/pubmed/37273802 http://dx.doi.org/10.1007/s10989-023-10516-3 |